KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme Group (CME) EBT: 2009-2025

Historic EBT for Cme Group (CME) over the last 17 years, with Sep 2025 value amounting to $1.2 billion.

  • Cme Group's EBT rose 0.01% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 billion, marking a year-over-year increase of 8.94%. This contributed to the annual value of $4.5 billion for FY2024, which is 9.34% up from last year.
  • As of Q3 2025, Cme Group's EBT stood at $1.2 billion, which was down 11.52% from $1.3 billion recorded in Q2 2025.
  • Cme Group's 5-year EBT high stood at $1.3 billion for Q2 2025, and its period low was $726.1 million during Q2 2021.
  • Over the past 3 years, Cme Group's median EBT value was $1.2 billion (recorded in 2024), while the average stood at $1.1 billion.
  • The largest annual percentage gain for Cme Group's EBT in the last 5 years was 104.27% (2021), contrasted with its biggest fall of 23.96% (2021).
  • Cme Group's EBT (Quarterly) stood at $799.3 million in 2021, then climbed by 3.50% to $827.3 million in 2022, then increased by 21.60% to $1.0 billion in 2023, then increased by 9.01% to $1.1 billion in 2024, then climbed by 0.01% to $1.2 billion in 2025.
  • Its EBT stands at $1.2 billion for Q3 2025, versus $1.3 billion for Q2 2025 and $1.2 billion for Q1 2025.